OVERVIEW
The market size of the Genotyping Assay is expected to reach USD 34.2 billion by 2024, increasing at CAGR by 21.54% during the forecast period. The main factors expected to drive the market for genotyping assays are technological advances and declining DNA sequencing prices. In addition, the growing prevalence of genetic diseases and knowledge of personalized medicine, the rising importance of genotyping in drug development and the increasing demand for bioinformatics solutions in data analysis are also expected to support market growth in the coming years.
TABLE OF CONTENT
1 Global Genotyping Assay Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Genotyping Assay Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Genotyping Assay Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Genotyping Assay Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Genotyping Assay Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Genotyping Assay Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Genotyping Assay Market – By Product & Service (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Genotyping Services
8.3 Instruments
8.4 Bioinformatics
9 Global Genotyping Assay Market – By Technology
9.1 Microarrays
9.2 Sequencing
9.3 PCR
9.4 Capillary Electrophoresis
9.5 Other
10 Global Genotyping Assay Market – By Application
10.1 Agricultural Biotechnology
10.2 Animal Genetics
10.3 Diagnostic & Personalized Medicine
10.4 Pharmacogenomics
10.5 Other
11 Global Genotyping Assay Market – By End-User
11.1 Pharmaceutical and Biopharmaceutical Companies
11.2 Diagnostic and Research Laboratories
11.3 Academic Institutes
11.4 Other
12 Global Genotyping Assay Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Genotyping Assay Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Genotyping Assay Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Roche Diagnostics Limited
14.3 Thermo Fisher Scientific, INC.
14.4 Illumina
14.5 Agilent Technologies, INC.
14.6 Fluidigm Corporation
14.7 GE Healthcare
14.8 Genewiz, INC.
14.9 Danaher Corporation
14.10 Qiagen N.V.
14.11 Company 10
14.12 Company 11 & more
15 Global Genotyping Assay Market – Appendix
15.1 Sources
15.2 Abbreviations
